Effect of supplementation in treatment of patients with gestational diabetes

Phase 2

• Conditions: Gestational diabetes.; Diabetes mellitus in pregnancy, unspecified

• Registration Number: IRCT20171010036697N1
• Lead Sponsor: Vice chancellor for research, Kashan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 50

Inclusion Criteria

patients with gestational diabetes; aged 18 to 40 years old

Exclusion Criteria

Exclusion criterion: unwillingness to cooperate

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Expressed levels of PPAR-? gene. Timepoint: At the beginning of the study and 6 weeks after intervention. Method of measurement: PCR.;Expressed levels of GLUT-1 gene. Timepoint: At the beginning of the study and 6 weeks after intervention. Method of measurement: PCR.

Secondary Outcome Measures

Name	Time	Method
Expressed levels of TNF-a gene. Timepoint: At the beginning of the study and 6 weeks after intervention. Method of measurement: PCR.;Expressed levels of IL-8 gene. Timepoint: At the beginning of the study and 6 weeks after intervention. Method of measurement: PCR.;Expressed levels of IL-1 gene. Timepoint: At the beginning of the study and 6 weeks after intervention. Method of measurement: PCR.;Expressed levels LDLR gene. Timepoint: At the beginning of the study and 6 weeks after intervention. Method of measurement: PCR.;Expressed levels of LPa gene. Timepoint: At the beginning of the study and 6 weeks after intervention. Method of measurement: PCR.